About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 302 record(s)
Req # A-2022-000816
The most current Canadian Risk Management Plan (RMP) or Canadian Addendum to the RMP and Canadian RMP review report for NEUPOGEN by Amgen Canada Inc., Drug Identification Numbers (DINs) 01968017, 02420104, and 02420112.Organization: Health Canada
December 2022
Req # A-2022-000835
All expense claims and receipts above one hundred dollars from November 20th, 2019 to September 20th, 2022 incurred by the Minister of Health Canada and the Chief of Staff.Organization: Health Canada
December 2022
Req # A-2022-000854
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-09-16 for the medicinal ingredient glatiramer. The…Organization: Health Canada
December 2022
Req # A-2022-000873
Information for all complaints posted against Signatories of the letter (healthcare workers) and involvement of HLS Therapeutics - in relation to health product advertising incidents. All information in relation to incidents received by Health…Organization: Health Canada
December 2022
Req # A-2022-000990
Any cancellation letter(s)/ correspondence which prompted the removal of Degarelix acetate from the Generic Drugs Under Review List dated October 20, 2022.Organization: Health Canada
December 2022
Req # A-2021-400
Any contact between CSIS and McGill University. Any reports about research, information or data collected from McGill University by CSIS.Organization: Canadian Security Intelligence Service
December 2021
Req # A-2021-413
Any briefing notes or draft letters for the Minister of Public Safety and Emergency Preparedness reviewed or approved by Assistant Director Tricia Geddes concerning the Government’s proposed approach to addressing harmful online content for the time…Organization: Canadian Security Intelligence Service
December 2021
Req # A-2021-446
Briefing note: Ref # DDC21-37401Organization: Canadian Security Intelligence Service
December 2021
Req # A-2021-451
Any and all files relating to Dr. Donald Ewen Cameron, and to the work done at Montreal's Allen Institute between the years of 1953 and 1967.Organization: Canadian Security Intelligence Service
December 2021
Req # A-2021-471
An up-to-date organizational chart for CSIS down to the division level.Organization: Canadian Security Intelligence Service
December 2021